Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Concurrent Chemoradiotherapy
100%
Rectal Adenocarcinoma
100%
Predictive Biomarker
100%
MiR-125b
100%
Non-responders
57%
Locally Advanced Rectal Cancer
57%
Colorectal Cancer
28%
MicroRNA
28%
Biopsy Specimen
28%
Tumor Regression Grade
28%
Microarray Analysis
14%
Quantitative PCR
14%
In Situ Hybridization
14%
Serum Levels
14%
Discriminatory Power
14%
Treatment Response
14%
Serum Samples
14%
MiR-200a
14%
Therapeutic Management
14%
Biomarkers of Response
14%
Pathological Response
14%
Clinical Impact
14%
Rectal Cancer Treatment
14%
Non-invasive Biomarkers
14%
Chemoradiotherapy Followed by Surgery
14%
Cancer Biopsy
14%
Complete Pathological Response
14%
MiR-338-3p
14%
MiR-409-3p
14%
MiR-30e
14%
MiR-214
14%
MiR-127-3p
14%
MiR-299-5p
14%
MiRNA Microarray
14%
MiR-378
14%
MiR-154
14%
MiR-33a
14%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Chemoradiation Therapy
100%
Rectum Carcinoma
100%
microRNA 125b
100%
Rectum Cancer
57%
microRNA
42%
Tumor Regression
28%
Malignant Neoplasm
14%
microRNA 200a
14%
microRNA 214
14%
Immunology and Microbiology
Blood Level
100%
Quantitative Reverse Transcription Polymerase Chain Reaction
100%
In Situ Hybridization
100%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Blood Level
50%
Quantitative Reverse Transcription Polymerase Chain Reaction
50%
In Situ Hybridization
50%
Neuroscience
microRNA 125b
100%
MicroRNA
42%
In Situ Hybridization
14%
Mir-127
14%
microRNA 200a
14%
microRNA 214
14%